Central and peripheral role of the nociceptin/orphaninFQ system on normal and disturbed colonic motor function and faecal pellet output in the rat
- 18 July 2008
- journal article
- Published by Wiley in Neurogastroenterology & Motility
- Vol. 20 (8) , 939-948
Abstract
Abstract In this study, seeking further information on the role of the nociceptin/orphanin FQ (N/OFQ)‐ergic system in normal and disturbed colonic motor function in rats, we compared the colonic effects of UFP‐112, a novel highly potent agonist, with those of N/OFQ. When injected intracerebroventricularly (i.c.v.) and intraperitoneally (i.p.), UFP‐112 and N/OFQ increased bead expulsion time in a statistically significant and dose‐related manner and reduced the percentage of rats with castor oil‐induced diarrhoea. UFP‐112 showed greater efficacy, higher potency and longer‐lasting inhibitory effects than N/OFQ, and pretreatment with UFP‐101, a selective antagonist, blocked the N/OFQ analogue‐induced responses in both tests. When injected i.c.v., UFP‐112 and N/OFQ inhibited corticotrophin releasing factor‐ and restrain stress‐stimulated faecal pellet excretion significantly and in a dose‐related manner. Conversely, when injected peripherally both peptides significantly inhibited colonic propulsive motility but did so in a non‐dose‐related manner. In conclusion, these findings indicate that, in the rat, the central and peripheral N/OFQ systems have an inhibitory role in modulating distal colonic propulsive motility under physiological and pathological conditions. UFP‐112 therefore promises to be a useful pharmacological tool for investigating the role of the N/OFQ system in motor functions in the distal colonic tract under physiological and pathological conditions.Keywords
This publication has 43 references indexed in Scilit:
- In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptorPeptides, 2007
- The effects of [Arg14, Lys15] nociceptin/orphanin FQ, a highly potent agonist of the NOP receptor, on in vitro and in vivo gastrointestinal functionsPeptides, 2005
- Role of peripheral CRF signalling pathways in stress‐related alterations of gut motility and mucosal functionNeurogastroenterology & Motility, 2004
- Pharmacology of nociceptin and its receptor: a novel therapeutic targetBritish Journal of Pharmacology, 2000
- Opioid receptor-like (ORL1) receptor distribution in the rat central nervous system: Comparison of ORL1 receptor mRNA expression with125I-[14Tyr]-orphanin FQ bindingJournal of Comparative Neurology, 1999
- Immunohistochemical localization of ORL-1 in the central nervous system of the ratJournal of Comparative Neurology, 1996
- Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptorNature, 1995
- Effect of selective mu1, mu2 and delta2 opioid receptor agonists on gastric functions in the ratNeuropharmacology, 1994
- Molecular cloning and tissue distribution of a putative member of the rat opioid receptor gene family that is not a μ, δ or κ opioid receptor typeFEBS Letters, 1994
- Colonic bead expulsion time in normal and μ-opioid receptor deficient (CXBK) mice following central (ICV) administration of μ- and δ-opioid agonistsLife Sciences, 1987